Morgan Stanley Infrastructure Partners Completes Investment in SpecialtyCare
29 Outubro 2021 - 1:45PM
Business Wire
Investment funds managed by Morgan Stanley Infrastructure
Partners (“MSIP”), a private infrastructure team within Morgan
Stanley Investment Management, announced today that they have
acquired SpecialtyCare, Inc. (“SpecialtyCare” or the “Company”)
from Kohlberg & Company, LLC (“Kohlberg”).
SpecialtyCare operates the leading network of outsourced
clinical services to hospital operating rooms in the U.S. With
1,200+ client hospitals in 46 U.S. states, it is the leading
provider of cardiovascular perfusion, extracorporeal membrane
oxygenation (“ECMO”), intraoperative neuromonitoring (“IONM”), and
autologous perfusion services (“ATS”). Furthermore, SpecialtyCare
is a leading provider of sterile processing services, endoscopic
support and surgical assistance.
“We believe that SpecialtyCare provides an essential solution to
its partners in an industry with considerable tailwinds through a
contracted business model. We look forward to building upon the
Company’s successful track record and further supporting their
growth trajectory,” said Chris Ortega, Managing Director and Head
of the Americas for MSIP.
Sam Weinstein, SpecialtyCare’s CEO said, “We are thrilled to be
aligned with MSIP as we continue to pursue opportunities to improve
patient care outcomes and grow our impact. We believe working with
MSIP can allow us to further invest in our team with a continued
focus on enhancing our strong culture.”
About Morgan Stanley Infrastructure Partners
Morgan Stanley Infrastructure Partners (“MSIP”) is a leading
global private infrastructure investment platform with over $16
billion in assets under management1. Founded in 2006, MSIP has
invested in a diverse portfolio of over 30 investments across
transport, digital infrastructure, energy transition and utilities.
MSIP targets assets that provide essential public goods and
services with the potential for value creation through active asset
management. For further information about Morgan Stanley
Infrastructure Partners, please visit
www.morganstanley.com/im/infrastructurepartners.
About SpecialtyCare
With over 1,500 clinicians supporting over 500,000 procedures
annually, SpecialtyCare provides high quality people, services, and
technology to the operating room. More than 1,200+ hospitals and
13,500 physicians trust SpecialtyCare to help them achieve
exceptional care outcomes, regulatory compliance, and financial
results. By maintaining the SpecialtyCare Operative Procedural
Registry (SCOPE™), the largest procedural database of its kind,
SpecialtyCare identifies standards, determines benchmarks,
disseminates best practices, and fosters innovations and
efficiencies that improve patient outcomes. Accredited and
certified by The Joint Commission, SpecialtyCare develops expertise
beyond industry requirements. Customers trust SpecialtyCare’s
highly trained clinicians delivering excellence in perfusion, ECMO,
intraoperative neuromonitoring, neurodiagnostic services,
autotransfusion, sterile processing management, surgical assist,
and minimally invasive surgical support.
_________________________ 1 AUM reflects assets managed by MSIP
platform since inception
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211029005441/en/
Media Relations: Lauren Bellmare, 212.761.5303
Morgan Stanley (NYSE:MS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Morgan Stanley (NYSE:MS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024